期刊文献+

c-erbB-2反义寡核苷酸对胃癌细胞株SGC7901的影响

Effect of C-erbB-2 antisense oligodeoxynucleotide in gastric cancer cell line SGC7901
暂未订购
导出
摘要 目的 观察c erbB 2反义寡核苷酸 (ASODN)对胃癌细胞株SGC790 1细胞的影响。方法 采用脂质体c erbB 2反义 (ASODN)组及空白对照、错配 (SCODN)组转染SGC790 1细胞 ,采用Westernblot观察c erbB 2蛋白表达的变化 ,采用四氮唑盐 (MTT)比色法测定细胞增殖以及对顺铂细胞毒性的影响。结果 转染ASODN能特异性下调c erbB 2蛋白表达和抑制胃癌细胞增殖。此外 ,顺铂在空白组、ASODN组及SCODN组的抑制率分别为 ( 3 3 .3± 2 .0 ) %、( 4 9.9± 5 .9) %和 ( 3 4.8± 3 .0 ) %。与空白对照组相比 ,ASODN组的抑制率显著增加 (P <0 .0 1)。结论 c erbB Objective To explore the effects of c erbB 2 antisense oligodeoxynucleotides (ASODN) in gastric cancer cell line SGC7901. Methods c erbB 2 ASODN and controlled oligonucleotides (blank and mismatched) were transfected by lipofectin, and then Western blot was taken to observe the changes of c erbB 2 protein expression.The cell proliferations and cytotoxity of cisplatin were assessed by MTT. Results c erbB 2 ASODN could specifically reduce the c erbB 2 protein expression and inhibit the cellular proliferation in human gastric cancer cells line ( P <0.01). Besides,the inhibition rates of cisplatin in the blank and mismatched groups were (33.3±2.0) %,(49.9±5.9)% and (34.8±3.0)%, respectively. Compared with the controls, the inhibition rate of antisense group increased significantly ( P <0.01). Conclusion The data suggest that the c erbB 2 ASODN can inhibit the proliferation of gastric cancer cell line and enhance the cytotoxicity to cisplatin.
出处 《上海医学》 CAS CSCD 北大核心 2003年第6期312-314,共3页 Shanghai Medical Journal
关键词 胃癌 细胞株 SGC7901 c—erbB—2 反义寡核苷酸 四氮唑盐 Gastric cancer c erbB 2 Antisense oligodeoxynucleotide Cisplatin
  • 相关文献

参考文献11

  • 1沈梅,丰有吉,葛柏青,吴直江,朱铭伟.脂质体-C-erbB2反义脱氧寡核苷酸对卵巢癌细胞的作用[J].中华妇产科杂志,1999,34(8):485-487. 被引量:8
  • 2万田谟 见:姜泊 主编.真核细胞转染技术[A].见:姜泊,主编.分子生物学常用实验方法:第1版[C].北京:人民军医出版社,1996.156-157.
  • 3梁国栋.蛋白质的表达[A].见:梁国栋.主编.最新分子生物学实验技术:第1版[C].北京:科学出版社,2001.313-316.
  • 4Nakajima M, Sawada H, Yamada Y, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer, 1999 ,85:1894-1902.
  • 5Ross JS, Fletcher JA. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol, 1999 , 112(suppl 1) :S53-S67.
  • 6Selvaggi G, Scagliotti GV, Torri V, et al. HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival. Cancer, 2002 , 94 : 2669-2674.
  • 7Liu X, Pogo BG. Inhibition of c-erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides. Antisense Nucleic Acid Drug Dev, 1996, 6:9-16.
  • 8Colomer R, Lupu R, Bacus SS,et al. c-erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with c-erbB-2 oncogene amplification. Br J Cancer, 1994, 70: 819-825.
  • 9Yu D, Hung MC. Role of erbB2 in breast cancer chemosensitivity. Bioessays, 2000,22:673-680.
  • 10Pegram MD, Lipton A, Hayes DF,et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized antip185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol, 1998, 16: 2659-2671.

二级参考文献3

  • 1金志军,中华妇产科杂志,1995年,30卷,222页
  • 2杨静平,生物化学与生物物理学报,1993年,25卷,231页
  • 3吴令英,中华妇产科杂志,1996年,31卷,3期,168页

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部